Targeted Clinical Research to Address Select Viral Infections-An Adaptive Pharmacokinetic, Pharmacodynamic, Concentration Response Investigation of CMX-001 in the Infants with Neonatal Herpes (HSV) Followed by Randomized Assessment

Grant

Total Award Amount

  • 3711096.00
  • Direct Costs

  • 2770282.00
  • Sponsor Award Id

  • HHSN272201100038C
  • Contributor

  • David Kimberlin M.D.   Investigator  
  • Gary Cutter   Investigator  
  • Richard Whitley M.D.   Principal Investigator